Sonoma Pharmaceuticals launches Aquanil AD skin care line

Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) announced the launch of Aquanil AD, a dermatology product line developed for Persōn & Covey Inc. for distribution through over-the-counter channels in the United States.

The product line includes three items targeting sensitive skin: Aquanil AD Repair Mist for irritated or damaged skin, Aquanil AD Recovery Gel designed to reduce scar appearance, and Aquanil AD Rescue Serum for rashes, itching and irritation relief. All products use Sonoma's Microcyn technology based on stabilized hypochlorous acid.

"The incomparable safety profile of Sonoma's Microcyn technology made it an ideal choice for our Aquanil line and our commitment to providing relief for individuals with sensitive skin," said Marisa Brenninkmeyer, CEO of Persōn & Covey.

Amy Trombly, CEO of Sonoma, stated the company is "excited to partner with such a highly regarded company as Persōn & Covey, whose dedication to those with sensitive skin aligns with Sonoma's mission to provide safe and effective skin care solutions."

Sonoma Pharmaceuticals develops stabilized hypochlorous acid products for wound care, eye care, dermatological conditions, podiatry and animal health care applications. The company sells products directly or through partners in over 55 countries. Its principal office is in Boulder, Colorado, with manufacturing operations in Guadalajara, Mexico.

Persōn & Covey, founded in 1941, is a California-based family-owned company that develops therapeutic formulas for sun protection and dermatological care in partnership with the medical community.

You May Also Be Interested In

• Alphabet added to Dow Jones Industrial Average, Verizon dropped
• Gates Industrial launches three new bicycle belt drive sprocket families
• Axis Capital Limited Downgrades Tech Mahindra Ltd. (TECHM:IN) to Sell (4)